Intellectual Property India Publishes Patent Application for Compositions And Methods Comprising Small Nuclear Rna (snrna) For Treating Genetic Epilepsies

MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202617060434 A) filed by Regeneron Pharmaceuticals, Inc. on May 12, 2026, for Compositions And Methods Comprising Small Nuclear Rna (snrna) For Treating Genetic Epilepsies.

Inventors include Roth, Daniela; Batra, Ranjan; Lardelli Markmiller, Rea; Adams, Rachel A.; Parker, Melissa; and Knowland, Daniel A..

The application for the patent was published on June 26, 2026, under issue no. 26/2026.

Abstract: SnRNA systems targeting SCN1A or SYNGAP1 RNA sequences are disclosed herein. Further disclosed are methods of treating genetic epilepsies such as Dravet Syndrome or SYNGAP1-related epilepsy.

Disclaimer: Curated by HT Syndication.